Avicanna (AVCNF, $0.26) was one of the top gainers for the month, rising +2 to $0.26 per share. A.I.dvisor analyzed 258 stocks in the Pharmaceuticals: Other Industry for the month ending July 24, 2024 and discovered that of them (5) exhibited an Uptrend while of them (4) exhibited a Downtrend. A.I.dvisor found 262 similar cases when AVCNF's price went up within one month. In out of those 262 cases, AVCNF's price went down during the next month. Based on these historical data, A.I. thinks the odds an Uptrend reversal for AVCNF are